Jupiter Neurosciences(JUNS)

Focus: Jupiter Neurosciences is a public biotechnology company focused on developing therapies for central nervous system diseases, operating from Florida since 2003.

Neurology

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Funding Stage

PUBLIC

Open Jobs

About Jupiter Neurosciences

AI assessmentNot Hiring

No open roles listed right now. Follow Jupiter Neurosciences to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

0 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Revenue

$22K

FY2025

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Founded: 2003

SEC Filings: 2 available

Help build intelligence for Jupiter Neurosciences

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Public company status provides liquidity and access to capital markets for long-term R&D investment
Focused therapeutic area (CNS) allows for deep expertise development in a high-unmet-need field
20+ year operational history demonstrates durability as an organization

Watch Out For

No active job openings (0 current positions) signals organizational contraction or hiring freeze
FY2024 financials show $4.78M net loss against only $955K R&D spend and critically low $28K cash position—severe financial distress
Zero clinical trials across all phases and no disclosed product pipeline indicates minimal active development

Generated by Claude from Jupiter Neurosciences's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Financials (FY2025)

Revenue

$22K

R&D Spend

$493K(2260%)48%

Net Income

-$2M

Cash

$4M

Source: SEC 10-K Filing

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo